
Peptides
Les peptides sont des chaînes courtes d'acides aminés liées par des liaisons peptidiques, jouant un rôle essentiel en tant que molécules biologiques dans divers processus cellulaires. Ils fonctionnent comme hormones, neurotransmetteurs et molécules de signalisation, et sont largement utilisés dans les applications thérapeutiques et diagnostiques. Les peptides sont également cruciaux dans la recherche pour étudier les interactions protéiques, les activités enzymatiques et les voies de signalisation cellulaire. Chez CymitQuimica, nous proposons une large sélection de peptides de haute qualité pour soutenir vos besoins en recherche et développement en biotechnologie et en pharmacie.
Sous-catégories appartenant à la catégorie "Peptides"
30318 produits trouvés pour "Peptides"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Urocortin 1 (Mouse, Rat)-EIA Kit (1ea)
Urocortin 1 (Mouse, Rat)-EIA Kit is an antibody-based sandwich ELISA kit for the quantitative determination of urocortin 1 in mouse and rat serum. This kit is designed to measure urocortin 1 concentrations in samples with a high level of accuracy. The antibody used in this kit has been shown to react with rat and mouse urocortin 1.Degré de pureté :Min. 95%Neurokinin B (Human, Porcine, Bovine, Rat, Mouse)
As a member of the tachykinin neuropeptide family, Neurokinin B is involved in the dilation of blood vessels, the contraction of smooth muscles and the excitation of neurons. This product can be applied as a NK3 receptors selective agonist.Formule :C55H79N13O14S2CH3COOH•4H2ODegré de pureté :Min. 95%Masse moléculaire :1,312.49 g/molPleiotrophin, human
Human pleiotrophin is a peptide that belongs to the family of neuropeptides. It has been shown to bind to ion channels in the cell membrane and is believed to regulate their function. This protein also binds with high affinity to the receptor tyrosine kinase, which are important for many cellular functions including signal transduction and cell growth. Pleiotrophin has been used as a research tool for studying protein interactions and for understanding how ion channels work. It can be used to study the mechanisms of various diseases such as hypertension, asthma, and diabetes mellitus.Formule :C658H1079N197O198S12Degré de pureté :Min. 95%Masse moléculaire :15,302.6 g/molHuwentoxin IV
CAS :<p>Huwentoxin IV is a potent analgesic that has been shown to have antinociceptive properties in animals. Huwentoxin IV blocks the voltage-gated sodium channel NaV1.8 and prevents the transmission of pain signals to the brain. This drug has also been shown to inhibit the activity of voltage-gated potassium channels KV1.3 and KV1.5, which are involved in neuronal excitability, suggesting that huwentoxin IV may have other therapeutic applications. Huwentoxin IV interacts with disulfide bonds and is an effective inhibitor of voltage-gated sodium channels, but not voltage-gated potassium channels, at low concentrations (10 μM).</p>Formule :C174H278N52O51S6Degré de pureté :Min. 95%Masse moléculaire :4,107 g/mol[FITC]-pCREB (127-134) substrate
<p>The cyclic AMP (cAMP) response element binding protein (CREB) is a transcription factor that regulates the transcription of several genes that mediate important cellular processes. CREB is phosphorylated by several kinases, including PKA- Akt- and CamK I, II, and IV. Phosphorylated pCREB translocates to the nucleus, where it forms homodimers or heterodimers, and recruits p300/CREB binding protein (CBP) to initiate transcription of its target genes. pCREB is an important regulator of apoptosis and is also involved in modulating several immune processes and neuronal plasticity. CREB signalling has a critical role in the formation of memories and may be dysfunctional in the brains of Alzheimer's disease (AD).Peptide is labelled with an N-terminal 5-carboxyfluorescein (5-FAM), a widely used green fluorescent tag.</p>Masse moléculaire :1,572.6 g/molL-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate
CAS :<p>L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate is a medicinal compound that has shown promise as an anticancer agent. It is an analog of a naturally occurring tripeptide found in human urine and has been shown to inhibit the activity of certain kinases, which are enzymes that play a key role in cancer cell growth and survival. L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate induces apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of these kinases. This inhibitor has demonstrated potent anticancer activity against various human tumor types, including breast and lung cancer. The compound shows favorable pharmacokinetic properties and good tolerability in preclinical studies, making it a promising candidate for further development as an anticancer therapy.</p>Formule :C17H32N4O5S3•(C2HF3O2)xDegré de pureté :Min. 95%β-Defensin-1, human
<p>β-Defensin-1 is a member of the α-defensin family of antimicrobial peptides. It has been shown to be an activator of the LPS receptor and is involved in the regulation of ion channels in cells. β-Defensin-1 is a ligand for the GPR37 receptor and inhibits protein synthesis, which may be due to its ability to bind to other proteins, such as chemokines. β-Defensin-1 also has antibacterial activity against some strains of bacteria, including Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. <br>β-Defensin-1 is a high purity recombinant human protein that can be used as an inhibitor for pharmacological studies.</p>Formule :C167H256N48O50S6Degré de pureté :Min. 95%Masse moléculaire :3,928.5 g/molGaTx2
CAS :<p>GaTx2 is a costimulatory molecule that binds to the B7-1 and B7-2 receptors on the surface of antigen-presenting cells. GaTx2 has been shown to regulate transcriptional regulation, cellular growth, and physiological function in heart tissue. It is also involved in the development of cancer and autoimmune diseases. GaTx2 has biological properties that are similar to those of T lymphocyte growth factor (TGF) and basic fibroblast growth factor (bFGF). GaTx2 is also a whole-cell voltage clamp that can be used in tissue culture.</p>Formule :C125H199N39O47S6Degré de pureté :Min. 95%Masse moléculaire :3,192.6 g/molJingzhaotoxin III
CAS :<p>Jingzhaotoxin III is a small peptide that has been expressed in Drosophila melanogaster and has been shown to have an inhibitory effect on brain natriuretic peptide (BNP). Jingzhaotoxin III decreases the amplitude of BNP-induced camp levels, and this decrease can be reversed by removing extracellular calcium. Jingzhaotoxin III also has a voltage-gated sodium channel blocking effect, which can be inhibited by adding extracellular calcium. Jingzhaotoxin III interacts with calyces and blocks their activation. This inhibition of calyx activation is reversible when extracellular calcium is removed.</p>Formule :C174H241N47O46S6Degré de pureté :Min. 95%Masse moléculaire :3,919 g/molAngiotensin IV trifluoroacetate
CAS :Angiotensin IV trifluoroacetate is an active analogue of angiotensin. It has been shown to have a high affinity for AT1 receptors and is able to enhance the uptake of angiotensin in proximal tubules, which may be due to its ability to bind DNA. Angiotensin IV trifluoroacetate has also been shown to have beneficial effects on skin cells, such as the reduction of skin inflammation and alleviation of pain. Angiotensin IV trifluoroacetate has shown anti-inflammatory activities, which may be due to its ability to reduce pro-inflammatory cytokines such as IL-6 and TNF-α. This drug also binds to the CD4 receptor, thereby inhibiting inflammatory responses in autoimmune diseases.Mass spectrometry of peptides and proteins using digestion by a grape cysteine protease at pH 3Z Perutka, M Ã Â ebela - Journal of mass spectrometry, 2020 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.4444Integrating computational modeling and experimental assay to discover new potent ACE-inhibitory peptidesY Ren, Q Wang, S Chen, H Cao - Molecular Informatics, 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/minf.201300131Absorption of casein antihypertensive peptides through an in vitro model of intestinal epitheliumM del Mar Contreras , AI Sancho , I Recio, C Mills - Food Digestion, 2012 - Springerhttps://link.springer.com/article/10.1007/s13228-012-0020-2Enhanced recombinant expression and purification of human IRAP for biochemical and crystallography studiesL Sui , HC Guo - Biochemistry and Biophysics Reports, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2405580821001369The specific isolation of C-terminal peptides of proteins through a transamination reaction and its advantage for introducing functional groups into the peptideK Sonomura, H Kuyama , E Matsuo - Journal Devoted to , 2009 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.3920Fragmentation mechanisms of oxidized peptides elucidated by SID, RRKM modeling, and molecular dynamicsJM Spraggins , JA Lloyd, MV Johnston , J Laskin - Journal of the American , 2009 - Springerhttps://link.springer.com/article/10.1016/j.jasms.2009.04.012Gold ion-angiotensin peptide interaction by mass spectrometryJ Lee, LP Jayathilaka, S Gupta - Journal of the , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1007/s13361-011-0328-0Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidaseJ Lee , T Mustafa, SG McDowall - of Pharmacology and , 2003 - ASPEThttps://jpet.aspetjournals.org/content/305/1/205.shortA mechanistic investigation of the enhanced cleavage at histidine in the gas-phase dissociation of protonated peptidesG Tsaprailis, H Nair, W Zhong , K Kuppannan - Analytical , 2004 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac034971jStudy of secondary specificity of enteropeptidase in comparison with trypsinAG Mikhailova, VV Likhareva, BV Vaskovsky - Biochemistry , 2004 - Springerhttps://link.springer.com/article/10.1023/B:BIRY.0000040224.47278.3bFormule :C40H54N8O8•(C2HF3O2)xDegré de pureté :Min. 95%Masse moléculaire :774.9 g/molH-GPDC-OH
GPCD peptide; synthetic substrate that mimics the DPP-IV (dipeptidyl peptidase IV) natural substrate. 95%, TFA salt.GHRP 4 TFA
CAS :GHRP 4 TFA is a synthetic hexapeptide, which is derived from non-natural amino acids, with a primary function of stimulating the secretion of growth hormone (GH). The source of this peptide is chemical synthesis, using solid-phase peptide synthesis techniques that allow precise chain assembly. The mode of action of GHRP 4 involves binding to growth hormone secretagogue receptors (GHS-R) located in the pituitary gland and hypothalamus. This interaction triggers the release of endogenous growth hormone by mimicking the action of ghrelin, a natural endogenous ligand.In scientific research, GHRP 4 TFA is utilized to explore the physiological and cellular pathways involved in GH release and its systemic effects. Applications include studying metabolic regulation, muscle growth, and cellular proliferation. Additionally, its role in aging and age-related disorders makes it a valuable tool in gerontological studies. The peptide's ability to modulate endocrine responses is of interest for developing therapeutic approaches in GH deficiency and other metabolic disorders. However, research into its full biological effects and potential clinical applications is ongoing, emphasizing its utility in experimental and preclinical settings.Formule :C34H37N7O4Degré de pureté :Min. 95%Masse moléculaire :607.7 g/molL-Lysyl-L-cysteine trifluoroacetate
CAS :Please enquire for more information about L-Lysyl-L-cysteine trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormule :C9H19N3O3S•(C2HF3O2)xDegré de pureté :Min. 95%Tripartite Motif Containing 21 (RO52), human, recombinant
The Tripartite Motif Containing 21 protein (TRIM21) is a human recombinant that is expressed in E. coli. TRIM21 is a glycosylated polypeptide chain, which has been shown to interact with the HIV-1 Vpu protein. TRIM21 binds to the HIV-1 Vpu protein and prevents it from interacting with the CD4 molecule on T cells, thereby inhibiting viral replication. TRIM21 also has been shown to be involved in the regulation of mRNA stability and translation by binding to polyribosomes and preventing ribosomal translocation.Degré de pureté :Min. 95%Penta-O-glycosylated IgA1 Hinge Region Peptide
<p>GalNAc modified hinge region peptide. Supplied as the TFA salt.Soluble in water, 0.1mM.</p>Formule :C121H193N25O53Masse moléculaire :2,845.96 g/molTentaGel® Macrobead RAM particle size: 140 - 170 µm
Please enquire for more information about TentaGel® Macrobead RAM particle size: 140 - 170 µm including the price, delivery time and more detailed product information at the technical inquiry form on this pageDegré de pureté :Min. 95%8-Oxoguanine DNA Glycosylase, human, recombinant
8-Oxoguanine DNA glycosylase is a glycosylase enzyme that repairs the 8-oxoG DNA base. It has been purified from human and Escherichia coli cells and recombinantly produced in E. coli. The enzyme has a molecular mass of about 42 kDa and is composed of two polypeptide chains with an apparent molecular weight of 17 kDa each. 8-Oxoguanine DNA glycosylase has been shown to have a broad substrate range, including both oxidized and reduced forms of 8-oxoG, as well as other oxidized purine bases such as 7,8-dihydrothymine (8-hydroxyguanine) and 5,6-dihydrothymine (5,6-dihydroxyguanine). The enzyme catalyzes the removal of the damaged base from the DNA backbone without any concomitant chemical changes in the sugar or phosphate groupsDegré de pureté :Min. 95%Cyclin-Dependent Kinase Inhibitor 2A, human, recombinant
Cyclin-Dependent Kinase Inhibitor 2A (CDK2A) is a cyclin-dependent kinase inhibitor that inhibits the activity of cyclin-dependent kinases. CDK2A is a protein that belongs to the family of cyclin-dependent kinase inhibitors. It inhibits the activity of various cyclin-dependent kinases and prevents cell growth by suppressing protein synthesis. CDK2A is expressed in many human tissues, including erythrocytes, brain, heart, lung, muscle, pancreas, spleen, and testis. Cyclin-Dependent Kinase Inhibitor 2A can be used as an anti-cancer agent due to its ability to inhibit tumor proliferation.Degré de pureté :Min. 95%Apolipoprotein A1 Light Tryptic Peptide Standard (4nmol)
Apolipoprotein A1 light tryptic peptide standard for protein identification and quantitation studies. Apolipoprotein A1 is a structural component of high density lipoprotein (HDL) and is involved in cellular cholesterol homeostasis and reverse cholesterol transport.Degré de pureté :Min. 95%Ceruloplasmin Light Tryptic Peptide Standard (4nmol)
<p>A Ceruloplasmin Light Tryptic Peptide Standard for use in protein identification and quantitation studies. Ceruloplasmin is a serum ferroxidase key to transporting copper in the blood. It also plays a role in iron metabolism regulation and the pathogenesis of Wilson disease. Furthermore it has been found in elevated levels during inflammation.</p>Degré de pureté :Min. 95%Ac-Gly-Ala-Lys(Ac)-AMC
CAS :Ac-Gly-Ala-Lys(Ac)-AMC is a fluorescent compound that reacts to the presence of amino acids. It is used as a research chemical, speciality chemical, and versatile building block. Ac-Gly-Ala-Lys(Ac)-AMC has been shown to be useful in the synthesis of complex compounds and fine chemicals.Formule :C25H33N5O7Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :515.56 g/molAtrial natriuretic factor (1-28) (human) acetate
CAS :Please enquire for more information about Atrial natriuretic factor (1-28) (human) acetate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormule :C127H203N45O39S3•C2H4O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :3,140.5 g/molH-NVEDLSGGELQR-OH
<p>Peptide H-NVEDLSGGELQR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.</p>Hydroxyacyl-Coenzyme A Dehydrogenase, human, recombinant
Hydroxyacyl-Coenzyme A Dehydrogenase is an enzyme that catalyzes the oxidation of hydroxyacyl-CoA to form acetyl-CoA. It is a member of the short-chain dehydrogenases/reductases (SDR) superfamily. Hydroxyacyl-Coenzyme A Dehydrogenase is expressed in many tissues and has been shown to be essential for fatty acid synthesis and catabolism, as well as for the conversion of ketone bodies to acetyl-CoA. It also plays a role in cellular respiration and energy production.Degré de pureté :Min. 95%H-VVNQNAQAL-OH
<p>Peptide H-VVNQNAQAL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.</p>α-2-Macroglobulin Light Tryptic Peptide Standard (4nmol)
An Alpha-2-Macroglobulin light tryptic peptide standard for protein identification and quantitation studies. Alpha-2-Macroglobulin is a broad spectrum protease inhibitor which also plays roles in cell migration and in the binding of growth factors and cytokines.Degré de pureté :Min. 95%H-VLIQFLQK-OH
<p>Peptide H-VLIQFLQK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.</p>α 1 Antitrypsin Human
<p>α 1 Antitrypsin Human is a research tool that can be used in the study of protein interactions. It is a high-purity, recombinant, human α 1 antitrypsin with an N-terminal hexahistidine tag. It has been specifically designed for use in antibody production and as a pharmacological agent to inhibit trypsin-like enzymes.</p>Degré de pureté :Min. 95%Conantokin G trifluoroacetic acid
CAS :<p>Conantokin G trifluoroacetic acid is a peptide that is derived from the conantokins. It has been shown to have neuroprotective properties and inhibitory properties. Conantokin G trifluoroacetic acid binds to calcium in neuronal cells, which leads to the inhibition of glutamate-induced neuronal death and brain infarction. The binding of this peptide to calcium also inhibits intracellular signalling pathways, leading to an anti-inflammatory response. In addition, this compound may be a potential therapeutic agent for chronic oral toxicity due to its ability to bind with glutamate receptors and prevent activation.</p>Formule :C88H138N26O44•TFADegré de pureté :Min. 95%Masse moléculaire :2,264.21 g/molVGF Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of VGF antibody, catalog no. 70R-6218</p>Degré de pureté :Min. 95%CFP Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CFP antibody, catalog no. 70R-5908</p>Degré de pureté :Min. 95%HKR1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of HKR1 antibody, catalog no. 70R-8456</p>Degré de pureté :Min. 95%Zfp113 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Zfp113 antibody, catalog no. 70R-8906</p>Degré de pureté :Min. 95%GFPT2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of GFPT2 antibody, catalog no. 70R-8530</p>Degré de pureté :Min. 95%PCDH12 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PCDH12 antibody, catalog no. 70R-6110</p>Degré de pureté :Min. 95%IGFBP2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of IGFBP2 antibody, catalog no. 70R-5304</p>Degré de pureté :Min. 95%SH3BGRL Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SH3BGRL antibody, catalog no. 70R-3848</p>Degré de pureté :Min. 95%ZNF256 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF256 antibody, catalog no. 70R-8717</p>Degré de pureté :Min. 95%KHDRBS1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS1 antibody, catalog no. 20R-1132</p>Degré de pureté :Min. 95%ABAT Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ABAT antibody, catalog no. 70R-2214</p>CATSPER2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CATSPER2 antibody, catalog no. 70R-5069</p>Degré de pureté :Min. 95%FIP1L1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FIP1L1 antibody, catalog no. 70R-4866</p>Degré de pureté :Min. 95%SRRD Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SRRD antibody, catalog no. 70R-3668</p>Degré de pureté :Min. 95%NSF Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of NSF antibody, catalog no. 70R-4943</p>Degré de pureté :Min. 95%ZNF284 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF284 antibody, catalog no. 70R-8896</p>Degré de pureté :Min. 95%HSF1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of HSF1 antibody, catalog no. 70R-8193</p>Degré de pureté :Min. 95%PTDSS2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PTDSS2 antibody, catalog no. 70R-8842</p>Degré de pureté :Min. 95%CITED4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CITED4 antibody, catalog no. 20R-1141</p>Degré de pureté :Min. 95%CDH5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CDH5 antibody, catalog no. 70R-9984</p>Degré de pureté :Min. 95%LZTS2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LZTS2 antibody, catalog no. 70R-5687</p>Degré de pureté :Min. 95%Tmed1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Tmed1 antibody, catalog no. 70R-8661</p>Degré de pureté :Min. 95%PON1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PON1 antibody, catalog no. 70R-5362</p>Degré de pureté :Min. 95%SLC15A4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC15A4 antibody, catalog no. 70R-6546</p>Degré de pureté :Min. 95%KCND2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KCND2 antibody, catalog no. 70R-5109</p>Degré de pureté :Min. 95%JAZF1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of JAZF1 antibody, catalog no. 70R-8452</p>Degré de pureté :Min. 95%LIM2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LIM2 antibody, catalog no. 70R-7174</p>Degré de pureté :Min. 95%MAP3K15 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MAP3K15 antibody, catalog no. 70R-2087</p>Degré de pureté :Min. 95%DGCR8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR8 antibody, catalog no. 70R-4730</p>Degré de pureté :Min. 95%TNKS1BP1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TNKS1BP1 antibody, catalog no. 70R-2291</p>Degré de pureté :Min. 95%PGM2L1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PGM2L1 antibody, catalog no. 70R-3547</p>Degré de pureté :Min. 95%WBP2NL Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of WBP2NL antibody, catalog no. 70R-2017</p>Degré de pureté :Min. 95%PARVB Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PARVB antibody, catalog no. 70R-6053</p>Degré de pureté :Min. 95%TIPARP Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TIPARP antibody, catalog no. 70R-3180</p>Degré de pureté :Min. 95%ZNF547 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF547 antibody, catalog no. 20R-1098</p>Degré de pureté :Min. 95%TFAM Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Tfam antibody, catalog no. 70R-1948</p>Degré de pureté :Min. 95%LDLRAP1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LDLRAP1 antibody, catalog no. 70R-2837</p>Degré de pureté :Min. 95%CACNB2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LHPP antibody, catalog no. 70R-4027</p>Degré de pureté :Min. 95%CYP2R1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2R1 antibody, catalog no. 70R-8833</p>Degré de pureté :Min. 95%LOC390338 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LOC390338 antibody, catalog no. 70R-8037</p>Degré de pureté :Min. 95%Ppp2r2d Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Ppp2r2d antibody, catalog no. 70R-9373</p>Degré de pureté :Min. 95%EGF Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EGF antibody, catalog no. 70R-5697Degré de pureté :Min. 95%OR2C3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of OR2C3 antibody, catalog no. 70R-9859</p>Degré de pureté :Min. 95%SPATA7 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SPATA7 antibody, catalog no. 70R-4374</p>Degré de pureté :Min. 95%MAP2K3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MAP2K3 antibody, catalog no. 70R-2684</p>Degré de pureté :Min. 95%MSL3L2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MSL3L2 antibody, catalog no. 70R-9064</p>Degré de pureté :Min. 95%DAAM1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DAAM1 antibody, catalog no. 70R-2236</p>Degré de pureté :Min. 95%TRAPPC6B Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TRAPPC6B antibody, catalog no. 70R-3155</p>Degré de pureté :Min. 95%C8orf45 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C8orf45 antibody, catalog no. 70R-9222</p>Degré de pureté :Min. 95%PACRG Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PACRG antibody, catalog no. 70R-2550</p>Degré de pureté :Min. 95%CD55 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CD55 antibody, catalog no. 70R-10001</p>Degré de pureté :Min. 95%SHMT1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SHMT1 antibody, catalog no. 70R-2935</p>Degré de pureté :Min. 95%hCG_1646157 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1646157 antibody, catalog no. 70R-9034</p>Degré de pureté :Min. 95%Cytokeratin 84 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KRT84 antibody, catalog no. 70R-3002</p>Degré de pureté :Min. 95%LRRTM4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LRRTM4 antibody, catalog no. 70R-7442</p>Degré de pureté :Min. 95%ZADH2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZADH2 antibody, catalog no. 70R-3404</p>Degré de pureté :Min. 95%EMID2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of EMID2 antibody, catalog no. 70R-7507</p>Degré de pureté :Min. 95%MLSTD2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MLSTD2 antibody, catalog no. 70R-1829</p>Degré de pureté :Min. 95%ZFP287 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP287 antibody, catalog no. 20R-1161</p>Degré de pureté :Min. 95%EVI1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of EVI1 antibody, catalog no. 70R-4771</p>Degré de pureté :Min. 95%FSTL5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FSTL5 antibody, catalog no. 70R-1991</p>Degré de pureté :Min. 95%Endoglin Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ENG antibody, catalog no. 70R-1686</p>Degré de pureté :Min. 95%TBK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TBK1 antibody, catalog no. 70R-5838Degré de pureté :Min. 95%Armcx1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Armcx1 antibody, catalog no. 70R-8678</p>Degré de pureté :Min. 95%CHERP Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CHERP antibody, catalog no. 70R-5262</p>Degré de pureté :Min. 95%Podoplanin Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PDPN antibody, catalog no. 70R-6816</p>Degré de pureté :Min. 95%ARV1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ARV1 antibody, catalog no. 70R-6453</p>Degré de pureté :Min. 95%Rag1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Rag1 antibody, catalog no. 70R-8553</p>Degré de pureté :Min. 95%POLK Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of POLK antibody, catalog no. 70R-5522</p>Degré de pureté :Min. 95%RNF212 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RNF212 antibody, catalog no. 70R-2823</p>Degré de pureté :Min. 95%CDKL2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CDKL2 antibody, catalog no. 70R-3300</p>Degré de pureté :Min. 95%DPP10 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DPP10 antibody, catalog no. 70R-6500</p>Degré de pureté :Min. 95%TMCO6 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TMCO6 antibody, catalog no. 70R-3902</p>Degré de pureté :Min. 95%Pygm Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Pygm antibody, catalog no. 70R-8796</p>Degré de pureté :Min. 95%Rest Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Rest antibody, catalog no. 70R-8272</p>Degré de pureté :Min. 95%SRPRB Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SRPRB antibody, catalog no. 70R-6615</p>Degré de pureté :Min. 95%LANCL2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LANCL2 antibody, catalog no. 70R-2713</p>Degré de pureté :Min. 95%C9ORF4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf4 antibody, catalog no. 70R-6869</p>Degré de pureté :Min. 95%SUSD4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SUSD4 antibody, catalog no. 70R-6884</p>Degré de pureté :Min. 95%PGBD3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PGBD3 antibody, catalog no. 70R-1365</p>Degré de pureté :Min. 95%Esrrg Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Esrrg antibody, catalog no. 70R-7908</p>Degré de pureté :Min. 95%MAGEA9 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA9 antibody, catalog no. 70R-8268</p>Degré de pureté :Min. 95%UCHL1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of UCHL1 antibody, catalog no. 70R-9725</p>Degré de pureté :Min. 95%ASGR2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ASGR2 antibody, catalog no. 70R-2075</p>Degré de pureté :Min. 95%LONRF3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LONRF3 antibody, catalog no. 70R-2808</p>Degré de pureté :Min. 95%ERC1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ERC1 antibody, catalog no. 70R-9796</p>Degré de pureté :Min. 95%DDX5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DDX5 antibody, catalog no. 70R-1382</p>Degré de pureté :Min. 95%SCGN Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SCGN antibody, catalog no. 70R-2886</p>Degré de pureté :Min. 95%GMPS Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of GMPS antibody, catalog no. 70R-2088</p>Degré de pureté :Min. 95%SOX17 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SOX17 antibody, catalog no. 70R-7976</p>Degré de pureté :Min. 95%ARGFX Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ARGFX antibody, catalog no. 70R-8696</p>Degré de pureté :Min. 95%ANKRD5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD5 antibody, catalog no. 70R-3379</p>Degré de pureté :Min. 95%PPHLN1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PPHLN1 antibody, catalog no. 70R-9552</p>Degré de pureté :Min. 95%JMJD3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of JMJD3 antibody, catalog no. 70R-8465</p>Degré de pureté :Min. 95%ZNF791 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF791 antibody, catalog no. 70R-8445</p>Degré de pureté :Min. 95%DAZL Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DAZL antibody, catalog no. 70R-4671</p>Degré de pureté :Min. 95%ODF2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ODF2 antibody, catalog no. 70R-3915</p>Degré de pureté :Min. 95%FLJ11730 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ11730 antibody, catalog no. 70R-2391</p>Degré de pureté :Min. 95%UGT1A6 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of UGT1A6 antibody, catalog no. 70R-7546</p>Degré de pureté :Min. 95%C11ORF54 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C11orf54 antibody, catalog no. 70R-3456</p>Degré de pureté :Min. 95%EPX Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of EPX antibody, catalog no. 70R-5444</p>Degré de pureté :Min. 95%Syntrophin Beta 1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SNTB1 antibody, catalog no. 70R-6691</p>Degré de pureté :Min. 95%ATPAF1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ATPAF1 antibody, catalog no. 70R-9517</p>Degré de pureté :Min. 95%RORA Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RORA antibody, catalog no. 70R-1937</p>Degré de pureté :Min. 95%RNF8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RNF8 antibody, catalog no. 20R-1245</p>Degré de pureté :Min. 95%LOXL4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LOXL4 antibody, catalog no. 70R-10079</p>Degré de pureté :Min. 95%ABCG5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ABCG5 antibody, catalog no. 70R-6712</p>SLC7A8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC7A8 antibody, catalog no. 70R-1792</p>Degré de pureté :Min. 95%PTGES3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PTGES3 antibody, catalog no. 70R-2745</p>Degré de pureté :Min. 95%Osteomodulin Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of OMD antibody, catalog no. 70R-6074</p>Degré de pureté :Min. 95%Pnkd Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Pnkd antibody, catalog no. 70R-8613</p>Degré de pureté :Min. 95%PCDHGC3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PCDHGC3 antibody, catalog no. 70R-6138</p>Degré de pureté :Min. 95%NRG3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of NRG3 antibody, catalog no. 70R-6237</p>Degré de pureté :Min. 95%SGMS1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SGMS1 antibody, catalog no. 70R-7009</p>Degré de pureté :Min. 95%CACNB2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-1509</p>Degré de pureté :Min. 95%ITGBL1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ITGBL1 antibody, catalog no. 70R-1700</p>Degré de pureté :Min. 95%VPS4B Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of VPS4B antibody, catalog no. 70R-10350</p>Degré de pureté :Min. 95%TLR8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TLR8 antibody, catalog no. 70R-9660</p>Degré de pureté :Min. 95%ADARB1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ADARB1 antibody, catalog no. 70R-1550</p>Degré de pureté :Min. 95%Integrin α 8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ITGA8 antibody, catalog no. 70R-6849Degré de pureté :Min. 95%AMBN Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of AMBN antibody, catalog no. 70R-10326</p>Degré de pureté :Min. 95%POSTN Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of POSTN antibody, catalog no. 70R-6066</p>Degré de pureté :Min. 95%FADS1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FADS1 antibody, catalog no. 70R-7011</p>Degré de pureté :Min. 95%CCDC50 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CCDC50 antibody, catalog no. 70R-2218</p>Degré de pureté :Min. 95%P2RX2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of P2RX2 antibody, catalog no. 70R-5166</p>Degré de pureté :Min. 95%SF4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SF4 antibody, catalog no. 70R-4961</p>Degré de pureté :Min. 95%CYP7B1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of CYP7B1 antibody, catalog no. 70R-10195</p>Degré de pureté :Min. 95%THAP6 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of THAP6 antibody, catalog no. 70R-9200</p>Degré de pureté :Min. 95%Utx Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Utx antibody, catalog no. 70R-7989</p>Degré de pureté :Min. 95%PRDM13 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PRDM13 antibody, catalog no. 70R-8363</p>Degré de pureté :Min. 95%KLK-B1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of KLKB1 antibody, catalog no. 70R-1656</p>Degré de pureté :Min. 95%PCCB Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PCCB antibody, catalog no. 70R-5324</p>SLC39A8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC39A8 antibody, catalog no. 70R-6510</p>Degré de pureté :Min. 95%Fibronectin 1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FN1 antibody, catalog no. 70R-6082</p>Degré de pureté :Min. 95%ARL8A Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ARL8A antibody, catalog no. 70R-5793</p>Degré de pureté :Min. 95%TKTL1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TKTL1 antibody, catalog no. 70R-2668</p>Degré de pureté :Min. 95%PCSK2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PCSK2 antibody, catalog no. 70R-9811</p>Degré de pureté :Min. 95%SLC26A5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26A5 antibody, catalog no. 70R-1782</p>Degré de pureté :Min. 95%MMP24 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of MMP24 antibody, catalog no. 70R-6357</p>Degré de pureté :Min. 95%TNFRSF21 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TNFRSF21 antibody, catalog no. 70R-7549</p>Degré de pureté :Min. 95%Chodl Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of Chodl antibody, catalog no. 70R-9251</p>Degré de pureté :Min. 95%TAF9 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TAF9 antibody, catalog no. 70R-8040</p>Degré de pureté :Min. 95%EHD4 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of EHD4 antibody, catalog no. 70R-2681</p>Degré de pureté :Min. 95%STAMBP Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of STAMBP antibody, catalog no. 70R-5741</p>Degré de pureté :Min. 95%WDR6 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of WDR6 antibody, catalog no. 70R-2628</p>Degré de pureté :Min. 95%PILRB Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PILRB antibody, catalog no. 70R-7227</p>Degré de pureté :Min. 95%ZFP28 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP28 antibody, catalog no. 70R-8349</p>Degré de pureté :Min. 95%LBX2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LBX2 antibody, catalog no. 70R-8694</p>Degré de pureté :Min. 95%SLC13A3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SLC13A3 antibody, catalog no. 70R-1904</p>Degré de pureté :Min. 95%GSG1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of GSG1 antibody, catalog no. 70R-7536</p>Degré de pureté :Min. 95%SFRS3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SFRS3 antibody, catalog no. 70R-4718</p>Degré de pureté :Min. 95%PNKP Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PNKP antibody, catalog no. 70R-4477</p>Degré de pureté :Min. 95%PRKCG Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of PRKCG antibody, catalog no. 70R-5850</p>Degré de pureté :Min. 95%ALAD Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ALAD antibody, catalog no. 70R-8516</p>Degré de pureté :Min. 95%GRM6 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of GRM6 antibody, catalog no. 70R-7886</p>Degré de pureté :Min. 95%DCUN1D3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DCUN1D3 antibody, catalog no. 70R-3679</p>Degré de pureté :Min. 95%LDB3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of LDB3 antibody, catalog no. 70R-1141</p>Degré de pureté :Min. 95%FXYD5 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of FXYD5 antibody, catalog no. 70R-1682</p>Degré de pureté :Min. 95%NDUFS3 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of NDUFS3 antibody, catalog no. 70R-2515</p>Degré de pureté :Min. 95%SERAC1 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of SERAC1 antibody, catalog no. 70R-10152</p>Degré de pureté :Min. 95%DRGX Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of DRGX antibody, catalog no. 70R-8703</p>Degré de pureté :Min. 95%ALKBH8 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of ALKBH8 antibody, catalog no. 70R-5009</p>Degré de pureté :Min. 95%C20ORF111 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of C20orf111 antibody, catalog no. 70R-4348</p>Degré de pureté :Min. 95%OR2J2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of OR2J2 antibody, catalog no. 70R-9865</p>Degré de pureté :Min. 95%REG1B Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of REG1B antibody, catalog no. 70R-5333</p>Degré de pureté :Min. 95%TSSK2 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of TSSK2 antibody, catalog no. 70R-2083</p>Degré de pureté :Min. 95%RPS21 Blocking Peptide
<p>A synthetic peptide for use as a blocking control in assays to test for specificity of RPS21 antibody, catalog no. 70R-2535</p>Degré de pureté :Min. 95%
